THALIDOMIDE ACCORD 50 mg, hard capsule 28 capsules, CIP 3400955069652
Active ingredients: Thalidomide
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule28 capsules, CIP 3400955069652orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- THALIDOMIDE ACCORD 50 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) PVC polychlortrifluoroéthylène aluminium prédécoupées unitaires de 7 gélule(s)
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62638974CIP75506965CIP133400955069652Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| THALIDOMIDEgélule | 50 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.